Heart Function in Patients Assessed for Sleep Apnoea
1 other identifier
observational
101
1 country
1
Brief Summary
This study aims to determine the prevalence and prognosis of heart failure with preserved ejection function (HFpEF) among patients being assessed for sleep disordered breathing (SDB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2017
CompletedFirst Posted
Study publicly available on registry
July 24, 2017
CompletedStudy Start
First participant enrolled
July 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedResults Posted
Study results publicly available
February 17, 2021
CompletedFebruary 17, 2021
February 1, 2021
1.7 years
July 20, 2017
January 21, 2021
February 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Unrecognised Heart Failure With Preserved Ejection Fraction (HFpEF) in Cohort With Clinically Suspected Sleep Disordered Breathing (SDB)
The diagnosis of HFpEF was established using criteria set out in the European Society for Cardiology (ESC) guidelines based on clinical symptoms and/or signs, biomarker analysis (NT-proBNP) and evidence of structural cardiac remodeling or diastolic dysfunction on transthoracic echocardiography.
Baseline
Study Arms (1)
Patients with clinically suspected sleep disordered breathing (SDB)
Patients referred for Sleep disordered breathing assessment.
Eligibility Criteria
Patients referred from primary and secondary care for SDB assessment.
You may qualify if:
- Aged ≥40 years and referred for respiratory polygraphy
You may not qualify if:
- Previous diagnosis of Heart Failure
- Treated sleep disordered breathing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Brompton Hospital
London, SW3 6NP, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Professor M Cowie
- Organization
- Imperial College London
Study Officials
- PRINCIPAL INVESTIGATOR
Martin R Cowie, MD MSc
Imperial College London
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2017
First Posted
July 24, 2017
Study Start
July 24, 2017
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
February 17, 2021
Results First Posted
February 17, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share